Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

Nussenblatt, RB; Thompson, DJS; Li, Z; Peterson, JS; Robinson, RR; Shames, RS; Nagarajan, S; Tang, MT; Mailman, M; Velez, G; Roy, C; Levy-Clarke, GA; Suhler, EB; Djalilian, A; Sen, HN; Al-Khatib, S; Ursea, R; Srivastava, S; Bamji, A; Mellow, S; Sran, P; W